Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

5.41
-0.0900-1.64%
Post-market: 5.430.0200+0.37%18:18 EDT
Volume:13.52M
Turnover:73.30M
Market Cap:2.18B
PE:-3.20
High:5.65
Open:5.35
Low:5.28
Close:5.50
Loading ...
Dec 04, 2024

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS, INC.'s Officer Gibson Christopher proposes to sell 20000 Shares, with a total value of approximately $143,200.
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 26, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 04, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities